CAA 2026: The Next Big Shift in Employer Health Plan Transparency
The Consolidated Appropriations Act of 2026 is not the kind of legislation most employers are going to read from beginning to end.
VP of Employee Benefits · BHC Insurance · Independent Benefits Consultant
The Consolidated Appropriations Act of 2026 is not the kind of legislation most employers are going to read from beginning to end, and frankly, most probably will not hear much about it until their broker or TPA brings it up at renewal. That is a mistake. The CAA 2026 contains some of the most significant employer health plan transparency requirements since the ACA, and the employers who understand what it requires — and what it makes possible — will be in a fundamentally better position than those who do not.
What the CAA 2026 Actually Does
The CAA 2026 builds on the transparency framework established by the CAA 2021 and the No Surprises Act. Where those earlier laws focused primarily on hospital price transparency and surprise billing protections, the CAA 2026 extends transparency requirements deeper into the pharmacy benefit and plan administration space.
The law requires plan sponsors to receive detailed data on PBM compensation, drug pricing, and spread. It strengthens fiduciary standards for plan sponsors, making it clearer that employers have an obligation to actively monitor their health plan arrangements — not just sign contracts and hope for the best. And it creates new enforcement mechanisms that give the Department of Labor more tools to hold plan sponsors accountable when they fail to meet those obligations.
The Fiduciary Implications Are Real
One of the most significant aspects of the CAA 2026 is what it means for employer fiduciary duty. The law makes explicit what many benefits attorneys have been arguing for years: that plan sponsors have an obligation to understand what they are paying for and to ensure that plan arrangements are in the best interest of plan participants.
This is not a new legal concept — ERISA has always imposed fiduciary obligations on plan sponsors. But the CAA 2026 raises the bar by requiring employers to actually use the transparency data that is now available to them. An employer that receives PBM disclosure data and does nothing with it is in a weaker fiduciary position than one that reviews the data, asks questions, and takes action when the data reveals problems.
"The CAA 2026 makes explicit what many benefits attorneys have been arguing for years: that plan sponsors have an obligation to understand what they are paying for."
What Employers Need to Do Before Year-End
The most important thing employers can do right now is make sure they understand what data they are entitled to receive under the CAA 2026 and that they are actually requesting it. This means working with your TPA, PBM, and benefits advisor to ensure that the required disclosures are being made and that someone on your team — or your advisor — is reviewing them.
For employers with upcoming renewals, this is also an opportunity to renegotiate contracts with better information. The transparency data required by the CAA 2026 will reveal whether your current arrangements are competitive. If they are not, you have both the information and the leverage to make changes.
The Broader Trend: Employers as Informed Buyers
The CAA 2026 is part of a longer arc of legislation and regulation that is pushing the employer health plan market toward greater transparency and accountability. The direction of travel is clear: employers are expected to be informed, engaged buyers who actively manage their health plan arrangements rather than passive payers who accept whatever their vendors tell them.
For employers who have already been moving in this direction — working with independent advisors, using data to drive decisions, and holding vendors accountable — the CAA 2026 is a validation of that approach. For employers who have been more passive, it is a signal that the regulatory environment is changing and that the cost of inaction is increasing.
This post is the first in a three-part series on the CAA 2026. Part 1 covers the PBM transparency requirements in detail. Part 2 examines the rebate and compensation disclosure rules. If you want to understand how these requirements apply to your specific plan, the Compliance Health Check tool on this site is a good starting point.
Sources & Further Reading
- CMS — No Surprises Act — Surprise billing protections and price transparency requirements
- CMS — Hospital Price Transparency — Hospital standard charge disclosure requirements
- DOL — Consolidated Appropriations Act Guidance — CAA 2021 and subsequent transparency provisions for employer plans
- DOL — Fiduciary Responsibilities for Health Plans — ERISA fiduciary duty standards for plan sponsors
- Federal Register — MHPAEA and CAA Transparency Rules — Regulatory text and agency guidance on CAA transparency requirements
About the Author
Corry Hull, REBC®, CSFS®
VP of Employee Benefits · BHC Insurance
Corry Hull, REBC® CSFS®, is VP of Employee Benefits at BHC Insurance and the founder of Employer Benefits IQ (www.employerbenefitsiq.com). He is a Certified Health Rosetta Advisor — one of fewer than 200 nationwide — and a multi-year presenter at United Benefit Advisors (UBA) national conferences. He specializes in self-funded health plan design, PBM contract strategy, stop-loss structuring, group medical captives, and ACA/ERISA compliance for mid-market employers. His work has been recognized by Health Rosetta (Rosie Award, 2026), UBA (Producer Peak Performer, 2025–2024), and BHC Insurance (Producer of the Year, 2021–2025). His employer-education content has been referenced in BenefitsPro and cited within the Health Rosetta advisor community. All consulting and brokerage compensation is fully disclosed.